✦ LIBER ✦

PK/PD and Safety of a Single Dose of TMX‐67 (Febuxostat) in Subjects with Mild and Moderate Renal Impairment

✍ Scribed by Hoshide, S.; Takahashi, Y.; Ishikawa, T.; Kubo, J.; Tsuchimoto, M.; Komoriya, K.; Ohno, I.; Hosoya, T.

Book ID: 111980334
Publisher: Taylor and Francis Group
Year: 2004
Tongue: English
Weight: 83 KB
Volume: 23
Category: Article
ISSN: 0732-8311
DOI: 10.1081/ncn-200027377

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Single-Dose Pharmacokinetic Study of L

A Single-Dose Pharmacokinetic Study of Lasofoxifene in Healthy Volunteers and Subjects With Mild and Moderate Hepatic Impairment

✍ Bramson, Candace; Ouellet, Daniele; Roman, Doina; Randinitis, Edward; Gardner, M 📂 Article 📅 2006 🏛 Sage Publications 🌐 English ⚖ 110 KB

7055 POSTER A Phase 1 Single-dose Open-l

7055 POSTER A Phase 1 Single-dose Open-label Pharmacokinetic (PK) Study of Abiraterone Acetate (AA) in Male Subjects With Mild or Moderate Hepatic Impairment

✍ Marbury, T.; Stonerock, R.; Acharya, M.; Gonzalez, M.; Jiao, J.; Breeding, J.; H 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Sa1207 Pharmacokinetics/Pharmacodynamics

Sa1207 Pharmacokinetics/Pharmacodynamics (PK/PD), Efficacy, and Safety of AMG 181 in Subjects With Active, Mild to Moderate Ulcerative Colitis - An Initial Assessment

✍ Pan, Wei-Jian; Radford-Smith, Graham; Andrews, Jane M.; Schwartz, Howard I.; Sul 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 122 KB

Single-dose pharmacokinetics of nefazodo

Single-dose pharmacokinetics of nefazodone in healthy young and elderly subjects and in subjects with renal or hepatic impairment

✍ R. H. Barbhaiya; D. S. Greene; U. A. Shukla 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 658 KB

The single-dose pharmacokinetics of nefazodone (NEF) and its metabolites hydroxynefazodone (HO-NEF) and m-chlorophenylpiperazine (mCPP) were examined in 12 healthy younger subjects < 55 years of age (YNG), 12 elderly subjects > 65 years of age (ELD), 12 patients with biopsy proven hepatic cirrhosis

593 Pharmacokinetics (PK) and Pharmacody

593 Pharmacokinetics (PK) and Pharmacodynamics (PD) of Liposomal Mifamurtide (L-MTP-PE) in Adult Volunteers with Mild and Moderate Hepatic Impairment (HI)

✍ Venkatakrishnan, K.; Liu, Y.; Noe, D.; Mertz, J.; Mockler, M.; Marbury, T.; Farb 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Safety and Pharmacokinetics of a Single

Safety and Pharmacokinetics of a Single Oral Dose of Gatifloxacin in Patients with Moderate to Severe Hepatic Impairment

✍ Dr. Dennis M. Grasela; Ms. Barbara Christofalo; Dr. Georgia D. Kollia; Mr. Glenn 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB